Review



rabbit anti mouse epo  (Santa Cruz Biotechnology)


Bioz Verified Symbol Santa Cruz Biotechnology is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Santa Cruz Biotechnology rabbit anti mouse epo
    Rabbit Anti Mouse Epo, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 3875 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+mouse+epo/rabbit+anti-mouse+IgG-B/pm37611377-107-30-42
    Average 96 stars, based on 3875 article reviews
    rabbit anti mouse epo - by Bioz Stars, 2026-09
    96/100 stars

    Images

    Related Articles

    Incubation:

    Article Title: CCR3 gene knockout inhibits proliferation, differentiation, and migration of eosinophils in allergic rhinitis model mice.
    Article Snippet: Allergic rhinitis (AR) is characterized by various bothersome clinical symptoms of the nasal mucosa that impaired the quality of daily life.. Different chemokine receptors play a crucial role in the recruitment of inflammatory cells in AR.. However, the effect of CC chemokine receptor (CCR) 3 on the function of eosinophils (EOS) is still unclear.



    Similar Products

    94
    Cell Signaling Technology Inc mouse anti epo
    Mouse Anti Epo, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+mouse+epo/NSUN2+Rabbit+mAb/pmc11625042-45-77-85
    Average 94 stars, based on 1 article reviews
    mouse anti epo - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    96
    Santa Cruz Biotechnology rabbit anti mouse epo
    Rabbit Anti Mouse Epo, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+mouse+epo/rabbit+anti-mouse+IgG-B/pm37611377-107-30-42
    Average 96 stars, based on 1 article reviews
    rabbit anti mouse epo - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    90
    Beyotime rabbit anti-mouse epo receptor (epor
    HgCl 2 does not impact the production of <t>EPO,</t> but increases the expression of <t>EPOR</t> in EMPs in B10.S mice. EPO protein in the serum and BM, EPO mRNA in the kidney, and EPOR in EMPs in the BM in B10.S mice treated with 50 μM HgCl 2 or the control for 4 w were measured. FACS-purified EMPs from the BM of B10.S mice were treated with HgCl 2 or vehicle or EPO in vitro, and the Jak2/STAT5 signaling pathway and differentiation of EMPs were measured thereafter. ( A ) EPO protein (IU/L) in the serum of B10.S mice treated with 50 μM HgCl 2 or water for 4 w. ( B ) EPO protein (IU/g protein) in the BM of B10.S mice treated with 50 μM HgCl 2 or water for 4 w. ( C ) EPO mRNA (fold change) in the kidney of B10.S mice treated with 50 μM HgCl 2 or water for 4 w. ( D ) The expression of EPOR (MFI) in EMPs in the BM of B10.S mice treated with 50 μM HgCl 2 or water for 4 w. ( E ) The expression of EPOR mRNA (fold change) in FACS-purified EMPs from the BM of B10.S mice treated with 50 μM HgCl 2 or water for 4 w. ( F ) EMPs were purified from the BM of control B10.S mice, and the FACS-purified EMPs were treated thereafter with EPO or vehicle in vitro for 16 h. After that, the expression of p-Jak2 (MFI) in EMPs was measured. ( G ) EMPs were purified from the BM of control B10.S mice, and the FACS-purified EMPs were treated thereafter with EPO or vehicle in vitro for 16 h. After that, the expression of p-STAT5 (MFI) in EMPs was measured. ( H ) EMPs were purified from the BM of B10.S mice treated with 50μM HgCl 2 or water for 4 w, and the EMPs were treated thereafter with EPO or vehicle in the presence or absence of the Jak2 inhibitor fedratinib for 16 h in vitro. After that, the expression of p-STAT5 (MFI) in the EMPs was measured. ( I ) EMPs were purified from the BM of control B10.S mice, and the FACS-purified EMPs were treated thereafter with HgCl 2 and/or EPO or vehicle in vitro for 16 h. After that, the expression of p-Jak2 (MFI) in EMPs was measured. Each dot represents one mouse or one sample, and a total of 5 to 12 mice or samples were used for each group. Asterisk indicates a significant difference compared to the counterpart control group. p < 0.05 was considered as the level of significant difference.
    Rabbit Anti Mouse Epo Receptor (Epor, supplied by Beyotime, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+mouse+epo/rabbit+anti+mouse+epo+receptor++epor/pmc08537753-76-92-97
    Average 90 stars, based on 1 article reviews
    rabbit anti-mouse epo receptor (epor - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    95
    Santa Cruz Biotechnology rabbit anti mouse epo monoclonal antibody
    HgCl 2 does not impact the production of <t>EPO,</t> but increases the expression of <t>EPOR</t> in EMPs in B10.S mice. EPO protein in the serum and BM, EPO mRNA in the kidney, and EPOR in EMPs in the BM in B10.S mice treated with 50 μM HgCl 2 or the control for 4 w were measured. FACS-purified EMPs from the BM of B10.S mice were treated with HgCl 2 or vehicle or EPO in vitro, and the Jak2/STAT5 signaling pathway and differentiation of EMPs were measured thereafter. ( A ) EPO protein (IU/L) in the serum of B10.S mice treated with 50 μM HgCl 2 or water for 4 w. ( B ) EPO protein (IU/g protein) in the BM of B10.S mice treated with 50 μM HgCl 2 or water for 4 w. ( C ) EPO mRNA (fold change) in the kidney of B10.S mice treated with 50 μM HgCl 2 or water for 4 w. ( D ) The expression of EPOR (MFI) in EMPs in the BM of B10.S mice treated with 50 μM HgCl 2 or water for 4 w. ( E ) The expression of EPOR mRNA (fold change) in FACS-purified EMPs from the BM of B10.S mice treated with 50 μM HgCl 2 or water for 4 w. ( F ) EMPs were purified from the BM of control B10.S mice, and the FACS-purified EMPs were treated thereafter with EPO or vehicle in vitro for 16 h. After that, the expression of p-Jak2 (MFI) in EMPs was measured. ( G ) EMPs were purified from the BM of control B10.S mice, and the FACS-purified EMPs were treated thereafter with EPO or vehicle in vitro for 16 h. After that, the expression of p-STAT5 (MFI) in EMPs was measured. ( H ) EMPs were purified from the BM of B10.S mice treated with 50μM HgCl 2 or water for 4 w, and the EMPs were treated thereafter with EPO or vehicle in the presence or absence of the Jak2 inhibitor fedratinib for 16 h in vitro. After that, the expression of p-STAT5 (MFI) in the EMPs was measured. ( I ) EMPs were purified from the BM of control B10.S mice, and the FACS-purified EMPs were treated thereafter with HgCl 2 and/or EPO or vehicle in vitro for 16 h. After that, the expression of p-Jak2 (MFI) in EMPs was measured. Each dot represents one mouse or one sample, and a total of 5 to 12 mice or samples were used for each group. Asterisk indicates a significant difference compared to the counterpart control group. p < 0.05 was considered as the level of significant difference.
    Rabbit Anti Mouse Epo Monoclonal Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+mouse+epo/Epo+Antibody/pmc05746301-63-8-24
    Average 95 stars, based on 1 article reviews
    rabbit anti mouse epo monoclonal antibody - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    96
    Santa Cruz Biotechnology rabbit anti mouse epo r carboxyl terminal polyclonal antibody
    HgCl 2 does not impact the production of <t>EPO,</t> but increases the expression of <t>EPOR</t> in EMPs in B10.S mice. EPO protein in the serum and BM, EPO mRNA in the kidney, and EPOR in EMPs in the BM in B10.S mice treated with 50 μM HgCl 2 or the control for 4 w were measured. FACS-purified EMPs from the BM of B10.S mice were treated with HgCl 2 or vehicle or EPO in vitro, and the Jak2/STAT5 signaling pathway and differentiation of EMPs were measured thereafter. ( A ) EPO protein (IU/L) in the serum of B10.S mice treated with 50 μM HgCl 2 or water for 4 w. ( B ) EPO protein (IU/g protein) in the BM of B10.S mice treated with 50 μM HgCl 2 or water for 4 w. ( C ) EPO mRNA (fold change) in the kidney of B10.S mice treated with 50 μM HgCl 2 or water for 4 w. ( D ) The expression of EPOR (MFI) in EMPs in the BM of B10.S mice treated with 50 μM HgCl 2 or water for 4 w. ( E ) The expression of EPOR mRNA (fold change) in FACS-purified EMPs from the BM of B10.S mice treated with 50 μM HgCl 2 or water for 4 w. ( F ) EMPs were purified from the BM of control B10.S mice, and the FACS-purified EMPs were treated thereafter with EPO or vehicle in vitro for 16 h. After that, the expression of p-Jak2 (MFI) in EMPs was measured. ( G ) EMPs were purified from the BM of control B10.S mice, and the FACS-purified EMPs were treated thereafter with EPO or vehicle in vitro for 16 h. After that, the expression of p-STAT5 (MFI) in EMPs was measured. ( H ) EMPs were purified from the BM of B10.S mice treated with 50μM HgCl 2 or water for 4 w, and the EMPs were treated thereafter with EPO or vehicle in the presence or absence of the Jak2 inhibitor fedratinib for 16 h in vitro. After that, the expression of p-STAT5 (MFI) in the EMPs was measured. ( I ) EMPs were purified from the BM of control B10.S mice, and the FACS-purified EMPs were treated thereafter with HgCl 2 and/or EPO or vehicle in vitro for 16 h. After that, the expression of p-Jak2 (MFI) in EMPs was measured. Each dot represents one mouse or one sample, and a total of 5 to 12 mice or samples were used for each group. Asterisk indicates a significant difference compared to the counterpart control group. p < 0.05 was considered as the level of significant difference.
    Rabbit Anti Mouse Epo R Carboxyl Terminal Polyclonal Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+mouse+epo/VEGF/pm17513452-112-54-62
    Average 96 stars, based on 1 article reviews
    rabbit anti mouse epo r carboxyl terminal polyclonal antibody - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    90
    Santa Cruz Biotechnology mouse or rabbit anti-epo receptor
    HgCl 2 does not impact the production of <t>EPO,</t> but increases the expression of <t>EPOR</t> in EMPs in B10.S mice. EPO protein in the serum and BM, EPO mRNA in the kidney, and EPOR in EMPs in the BM in B10.S mice treated with 50 μM HgCl 2 or the control for 4 w were measured. FACS-purified EMPs from the BM of B10.S mice were treated with HgCl 2 or vehicle or EPO in vitro, and the Jak2/STAT5 signaling pathway and differentiation of EMPs were measured thereafter. ( A ) EPO protein (IU/L) in the serum of B10.S mice treated with 50 μM HgCl 2 or water for 4 w. ( B ) EPO protein (IU/g protein) in the BM of B10.S mice treated with 50 μM HgCl 2 or water for 4 w. ( C ) EPO mRNA (fold change) in the kidney of B10.S mice treated with 50 μM HgCl 2 or water for 4 w. ( D ) The expression of EPOR (MFI) in EMPs in the BM of B10.S mice treated with 50 μM HgCl 2 or water for 4 w. ( E ) The expression of EPOR mRNA (fold change) in FACS-purified EMPs from the BM of B10.S mice treated with 50 μM HgCl 2 or water for 4 w. ( F ) EMPs were purified from the BM of control B10.S mice, and the FACS-purified EMPs were treated thereafter with EPO or vehicle in vitro for 16 h. After that, the expression of p-Jak2 (MFI) in EMPs was measured. ( G ) EMPs were purified from the BM of control B10.S mice, and the FACS-purified EMPs were treated thereafter with EPO or vehicle in vitro for 16 h. After that, the expression of p-STAT5 (MFI) in EMPs was measured. ( H ) EMPs were purified from the BM of B10.S mice treated with 50μM HgCl 2 or water for 4 w, and the EMPs were treated thereafter with EPO or vehicle in the presence or absence of the Jak2 inhibitor fedratinib for 16 h in vitro. After that, the expression of p-STAT5 (MFI) in the EMPs was measured. ( I ) EMPs were purified from the BM of control B10.S mice, and the FACS-purified EMPs were treated thereafter with HgCl 2 and/or EPO or vehicle in vitro for 16 h. After that, the expression of p-Jak2 (MFI) in EMPs was measured. Each dot represents one mouse or one sample, and a total of 5 to 12 mice or samples were used for each group. Asterisk indicates a significant difference compared to the counterpart control group. p < 0.05 was considered as the level of significant difference.
    Mouse Or Rabbit Anti Epo Receptor, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+mouse+epo/epo+antibody/10__1523_slash_jneurosci__21___24___09733__2001-91-74-80
    Average 90 stars, based on 1 article reviews
    mouse or rabbit anti-epo receptor - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results


    HgCl 2 does not impact the production of EPO, but increases the expression of EPOR in EMPs in B10.S mice. EPO protein in the serum and BM, EPO mRNA in the kidney, and EPOR in EMPs in the BM in B10.S mice treated with 50 μM HgCl 2 or the control for 4 w were measured. FACS-purified EMPs from the BM of B10.S mice were treated with HgCl 2 or vehicle or EPO in vitro, and the Jak2/STAT5 signaling pathway and differentiation of EMPs were measured thereafter. ( A ) EPO protein (IU/L) in the serum of B10.S mice treated with 50 μM HgCl 2 or water for 4 w. ( B ) EPO protein (IU/g protein) in the BM of B10.S mice treated with 50 μM HgCl 2 or water for 4 w. ( C ) EPO mRNA (fold change) in the kidney of B10.S mice treated with 50 μM HgCl 2 or water for 4 w. ( D ) The expression of EPOR (MFI) in EMPs in the BM of B10.S mice treated with 50 μM HgCl 2 or water for 4 w. ( E ) The expression of EPOR mRNA (fold change) in FACS-purified EMPs from the BM of B10.S mice treated with 50 μM HgCl 2 or water for 4 w. ( F ) EMPs were purified from the BM of control B10.S mice, and the FACS-purified EMPs were treated thereafter with EPO or vehicle in vitro for 16 h. After that, the expression of p-Jak2 (MFI) in EMPs was measured. ( G ) EMPs were purified from the BM of control B10.S mice, and the FACS-purified EMPs were treated thereafter with EPO or vehicle in vitro for 16 h. After that, the expression of p-STAT5 (MFI) in EMPs was measured. ( H ) EMPs were purified from the BM of B10.S mice treated with 50μM HgCl 2 or water for 4 w, and the EMPs were treated thereafter with EPO or vehicle in the presence or absence of the Jak2 inhibitor fedratinib for 16 h in vitro. After that, the expression of p-STAT5 (MFI) in the EMPs was measured. ( I ) EMPs were purified from the BM of control B10.S mice, and the FACS-purified EMPs were treated thereafter with HgCl 2 and/or EPO or vehicle in vitro for 16 h. After that, the expression of p-Jak2 (MFI) in EMPs was measured. Each dot represents one mouse or one sample, and a total of 5 to 12 mice or samples were used for each group. Asterisk indicates a significant difference compared to the counterpart control group. p < 0.05 was considered as the level of significant difference.

    Journal: Toxics

    Article Title: Mercury Chloride Impacts on the Development of Erythrocytes and Megakaryocytes in Mice

    doi: 10.3390/toxics9100252

    Figure Lengend Snippet: HgCl 2 does not impact the production of EPO, but increases the expression of EPOR in EMPs in B10.S mice. EPO protein in the serum and BM, EPO mRNA in the kidney, and EPOR in EMPs in the BM in B10.S mice treated with 50 μM HgCl 2 or the control for 4 w were measured. FACS-purified EMPs from the BM of B10.S mice were treated with HgCl 2 or vehicle or EPO in vitro, and the Jak2/STAT5 signaling pathway and differentiation of EMPs were measured thereafter. ( A ) EPO protein (IU/L) in the serum of B10.S mice treated with 50 μM HgCl 2 or water for 4 w. ( B ) EPO protein (IU/g protein) in the BM of B10.S mice treated with 50 μM HgCl 2 or water for 4 w. ( C ) EPO mRNA (fold change) in the kidney of B10.S mice treated with 50 μM HgCl 2 or water for 4 w. ( D ) The expression of EPOR (MFI) in EMPs in the BM of B10.S mice treated with 50 μM HgCl 2 or water for 4 w. ( E ) The expression of EPOR mRNA (fold change) in FACS-purified EMPs from the BM of B10.S mice treated with 50 μM HgCl 2 or water for 4 w. ( F ) EMPs were purified from the BM of control B10.S mice, and the FACS-purified EMPs were treated thereafter with EPO or vehicle in vitro for 16 h. After that, the expression of p-Jak2 (MFI) in EMPs was measured. ( G ) EMPs were purified from the BM of control B10.S mice, and the FACS-purified EMPs were treated thereafter with EPO or vehicle in vitro for 16 h. After that, the expression of p-STAT5 (MFI) in EMPs was measured. ( H ) EMPs were purified from the BM of B10.S mice treated with 50μM HgCl 2 or water for 4 w, and the EMPs were treated thereafter with EPO or vehicle in the presence or absence of the Jak2 inhibitor fedratinib for 16 h in vitro. After that, the expression of p-STAT5 (MFI) in the EMPs was measured. ( I ) EMPs were purified from the BM of control B10.S mice, and the FACS-purified EMPs were treated thereafter with HgCl 2 and/or EPO or vehicle in vitro for 16 h. After that, the expression of p-Jak2 (MFI) in EMPs was measured. Each dot represents one mouse or one sample, and a total of 5 to 12 mice or samples were used for each group. Asterisk indicates a significant difference compared to the counterpart control group. p < 0.05 was considered as the level of significant difference.

    Article Snippet: Ab (clone) and fluorescein used to stain progenitors, erythroblasts and leukocytes included lineage cocktail (Lin, CD3 (145-2C11), CD11b (M1/70), B220 (RA3-6B2), Gr-1 (RB6-8C5) and Ter119 (TER-119))-FITC or biotin, c-Kit-APC (2B8), Scal-1-PerCP-Cy5.5 (D7), CD150-PE-Cy7 (TC15-12F12.2), CD150-APC (TC15-12F12.2), CD41-FITC (MWReg30), CD41-PE (MWReg30), CD105-PB (MJ7/18); CD105-PE-Cy7 (MJ7/18), CD71-PE-Cy7 (RI7217), CD45-PE-Cy7 (30-F11), CD11b-PerCP-Cy5.5 (M1/70), Ly6G-PE (1/A8), F4/80-PE-Cy7 (BM8), Ki67-PE (16A8), p-STAT1-PE (pY701); p-STAT3-PE (Tyr705), streptavidin (SA)-PB, SA-APC-Cy7, anti-rabbit Ab-PE, anti-rabbit Ab-FITC and anti-rabbit Ab-APC (Biolegend, San Diego, CA, USA), and rabbit anti-mouse p-Jak1 (Tyr1022) (Nanjing Jiancheng, China), rabbit anti-mouse p-Jak2 (Tyr1007/1008), rabbit anti-mouse p-STAT5 (Tyr694), and rabbit anti-mouse EPO receptor (EPOR) (Beyotime Biotechnology, China), and rat anti-mouse CD16/32 (Fc block, 2.4G2) (BD Biosciences, San Diego, CA), and 4’6-diamidino-2-phenylindole (DAPI) (Sigma, St Louis, MO, USA).

    Techniques: Expressing, Purification, In Vitro

    A schematic model for the impact of Hg 2+ on erythro-megakaryopoiesis in mice. In hosts carrying certain H-2 haplotypes sensitive to Hg-induced autoimmunity (e.g., B10.S mice, H-2 s ), Hg 2+ induces an autoimmune environment, which leads to the increased expression of EPOR in EMPs and the resultant hypersensitivity of EMPs in response to EPO in the BM. Consequently, the Jak2/STAT5 signaling pathway is overactivated by EPO interaction with EPOR in EMPs, thus resulting in the increased production of RBCs and platelets in the BM. Hg 2+ does not impact erythro-megakaryopoiesis in mice carrying H-2 haplotypes resistant to Hg-induced autoimmunity (e.g., DBA/2 mice, H-2 d ).

    Journal: Toxics

    Article Title: Mercury Chloride Impacts on the Development of Erythrocytes and Megakaryocytes in Mice

    doi: 10.3390/toxics9100252

    Figure Lengend Snippet: A schematic model for the impact of Hg 2+ on erythro-megakaryopoiesis in mice. In hosts carrying certain H-2 haplotypes sensitive to Hg-induced autoimmunity (e.g., B10.S mice, H-2 s ), Hg 2+ induces an autoimmune environment, which leads to the increased expression of EPOR in EMPs and the resultant hypersensitivity of EMPs in response to EPO in the BM. Consequently, the Jak2/STAT5 signaling pathway is overactivated by EPO interaction with EPOR in EMPs, thus resulting in the increased production of RBCs and platelets in the BM. Hg 2+ does not impact erythro-megakaryopoiesis in mice carrying H-2 haplotypes resistant to Hg-induced autoimmunity (e.g., DBA/2 mice, H-2 d ).

    Article Snippet: Ab (clone) and fluorescein used to stain progenitors, erythroblasts and leukocytes included lineage cocktail (Lin, CD3 (145-2C11), CD11b (M1/70), B220 (RA3-6B2), Gr-1 (RB6-8C5) and Ter119 (TER-119))-FITC or biotin, c-Kit-APC (2B8), Scal-1-PerCP-Cy5.5 (D7), CD150-PE-Cy7 (TC15-12F12.2), CD150-APC (TC15-12F12.2), CD41-FITC (MWReg30), CD41-PE (MWReg30), CD105-PB (MJ7/18); CD105-PE-Cy7 (MJ7/18), CD71-PE-Cy7 (RI7217), CD45-PE-Cy7 (30-F11), CD11b-PerCP-Cy5.5 (M1/70), Ly6G-PE (1/A8), F4/80-PE-Cy7 (BM8), Ki67-PE (16A8), p-STAT1-PE (pY701); p-STAT3-PE (Tyr705), streptavidin (SA)-PB, SA-APC-Cy7, anti-rabbit Ab-PE, anti-rabbit Ab-FITC and anti-rabbit Ab-APC (Biolegend, San Diego, CA, USA), and rabbit anti-mouse p-Jak1 (Tyr1022) (Nanjing Jiancheng, China), rabbit anti-mouse p-Jak2 (Tyr1007/1008), rabbit anti-mouse p-STAT5 (Tyr694), and rabbit anti-mouse EPO receptor (EPOR) (Beyotime Biotechnology, China), and rat anti-mouse CD16/32 (Fc block, 2.4G2) (BD Biosciences, San Diego, CA), and 4’6-diamidino-2-phenylindole (DAPI) (Sigma, St Louis, MO, USA).

    Techniques: Expressing